Målsättningarna för helåret kvarstår och en FDA-ansökan närmar sig allt mer.
Fuud Q2 ’22: Weak Sales and Higher Costs
Redeye argues that the half-year report from Zwipe was softer than our expectations.
Redeye noted that Flexion’s revenue was above expectations, while its gross profit was in line.
Unchanged estimates ahead of Q2’22 We forecast sales and EBIT of DKK 1.
Redeye states that Sensys Gatso has gone through an impressive turnaround over the last few years an...
Redeye still regards Optomed’s current share price levels as an attractive long-term entry point, fo...
Redeye is only making some minor changes to estimates and valuation following the Q2 report.
We expect that Q2 was yet another strong quarter for Vow, which reports its H1 results on 25 August.
Investors House reported Q2 revenue of EUR 1.9m, 5% below our estimate, mainly owing to Services.
Trophy Games Development A/S (“Trophy Games” or the “Company”) is a Danish game developer focused on...
Transfer Group (”Transfer” eller ”bolaget”) publicerade idag den 19 augusti 2022 bolagets delårsrapp...
Odramatiska siffror Bolaget hade låga intäkter under Q2'22 i väntan på att försäljningen inom prepar...
Försäljningstillväxten trumfar kostnadsökningarna Trots att vi förväntade oss en bra utveckling för ...
Q2-rapporten Calliditas presenterade under torsdagen sin rapport för det andra kvartalet.
Alltainer publicerade den 22 augusti sin delårsrapport för bolagets fjärde kvartal 2021/2022, för pe...
Redeye sees some near-term challenges: growing operating losses and a looming capital raise.
Q2 numbers in line with ABGSC estimates We forecast H2’22e to grow by triple-digits Transfer of an...
Q2’22 marked another quarter with high sales growth for Nitro Games, albeit from modest levels.
Redeye tweaks its estimates amid higher ASP and lower volume than expected, resulting in ~7% lower H...
